Clinical trial Recruiting at 1 site Interventional Ages 18 and up Men only

Talking for Change — a program to help adults who are worried about sexually offending against children

Official title: Talking for Change: A Patient Preference Randomized Controlled Trial

Run by Centre for Addiction and Mental Health · NCT07001735 · Data updated 2026-11-12

This trial will see if a 20-week Talking for Change group psychotherapy helps adults who are concerned about their risk of sexually offending or accessing child sexual exploitation material reduce risk factors and harmful behaviors compared with a general mental-health group or no treatment.

More Child Abuse trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexMen only
Enrollment220 (estimated)
SponsorCentre for Addiction and Mental Health
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedApril 17, 2025
Main results expectedNovember 15, 2026
Study endsDecember 15, 2026
Registry record updatedJune 12, 2025
Trial IDNCT07001735 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older who are concerned about an elevated risk of sexually offending against children or accessing CSEM, have capacity to consent, and are referred to the TFC program are the intended participants.

Probably not a fit

People who require mandated tertiary offender treatment after conviction, who pose an immediate safety risk requiring legal intervention, or who cannot participate in outpatient group therapy are unlikely to benefit from this secondary-prevention program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This patient-preference randomized controlled trial compares three arms: a 20-week Talking for Change (TFC) group psychotherapy, a 20-week control group psychotherapy focused on general mental health and stress, and a no-treatment benchmarking arm. Blinded clinical raters will measure the primary outcome of reductions in dynamic risk factors for sexual offending, while participants will self-report changes in sexual contact with children, accessing child sexual exploitation material (CSEM), and sexual desire for children. Adults referred to the TFC program for concerns about elevated risk are eligible, and randomization accommodates participant preferences. The study is led by the Centre for Addiction and Mental Health in Toronto with collaboration from Johns Hopkins Bloomberg School of Public Health.

Why it matters

Potential benefit: If successful, the program could help at-risk adults manage factors that lead to offending and thereby reduce new incidents of child sexual abuse and online exploitation.

How similar studies have gone: Group psychotherapies for convicted sexual offenders have some evidence for reducing recidivism, but secondary-prevention programs like TFC are relatively novel and have limited prior evidence, especially in Canada.

Who can join: the full rules

Show full inclusion / exclusion criteria
INCLUSION CRITERIA:

For the treatment arms, the participant must meet all of the inclusion criteria to eligible for this clinical trial:

1. Must be deemed to have capacity to provide informed consent;
2. Must sign and date the informed consent form;
3. Stated willingness to comply with all study procedures;
4. Be 18 years of age or older upon study commencement;
5. Be referred for care in the TFC program due to concerns about enhanced risk of sexual offending against children.

For the benchmarking interview arm, the participant must meet all of the following inclusion criteria:

1. Must self-report concerns about enhanced risk of sexual offending against children
2. Must be deemed to have capacity to provide informed consent;
3. Must check the appropriate box on the informed consent form;
4. Stated willingness to comply with all study procedures;
5. Be 18 years of age or older upon study commencement.

For the benchmarking survey arm, participants must check the appropriate box on the informed consent form.

EXCLUSION CRITERIA:

For the treatment arms:

1. Inability to engage meaningfully in group psychotherapy (e.g., due to intellectual disability, other neurodiversity, active psychosis or substance use)
2. Those who self-identify as at-risk for reasons better accounted for by non-risk-relevant factors per clinical assessment (e.g., those with obsessive-compulsive disorder including thoughts about CSA, who commonly fear that they are at-risk but are not).
3. Non-male sex.

For the benchmarking interview arm:

1\. Non-male sex.

Where it's running

  • Centre for Addiction and Mental Health
    Toronto, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Artemis Igoumenou, M.D., Ph.D. — Complex Care and Recovery Program, Centre for Addiction and Mental Health (CAMH)
  • Study coordinator: Artemis Igoumenou, M.D., Ph.D.
  • Email: artemis.igoumenou@camh.ca
  • Phone: 416-535-8501

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.